Technical.ly Baltimore

Join us for Baltimore Innovation Week, Sept. 12 - 20, 2014

Business

Dec. 26, 2013 9:15 am

Intrexon acquires San Diego-based stem cell company for $26M

The Maryland synthetic biology company bought Medistem Inc., which has led the development of "universal donor adult stem cells."

Germantown-based biotech company Intrexon Corp. has acquired a San Diego-based company for $26 million.

According to CityBizList, the Maryland synthetic biology company bought Medistem Inc., which has led the development of “universal donor adult stem cells that stimulate new blood vessel formation and are capable of generating different tissues.”

In spring 2013, Intrexon raised more than $85 million in a new round of funding, preparation for its $160 million IPO, which happened in August. Founded in 1998, Intrexon so far is unprofitable.

-30-
Andrew Zaleski

Andrew Zaleski is a freelance journalist in Philadelphia and the former lead reporter for Technical.ly Baltimore. Before moving to Philadelphia in June 2014, he was a contributing writer to Baltimore City Paper and a Tech Check commentator for WYPR 88.1 FM, Baltimore city’s National Public Radio affiliate. He has written for The Atlantic, Outside, Richmond magazine, Washington City Paper, Baltimore magazine, Baltimore Style magazine, Next City, Grist.org, The Atlantic Cities, and elsewhere.

Profile   /   @ajzaleski   /   Send an email
Advertisement